IRF2 (Interferon Regulatory Factor 2) disruption has been associated with immune evasion phenotypes through a lack of MHC-I antigen presentation [48] and was detected as a pan-cancer tumor suppressor gene in Bailey et al. [24]. The gene discussed is IRF2; the disease is cancer.